Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,610 | 196 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $398.23 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $349.60 | 21 | $0 (2024) |
| PFIZER INC. | $310.66 | 17 | $0 (2024) |
| Amgen Inc. | $229.58 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $226.60 | 12 | $0 (2024) |
| Boston Scientific Corporation | $226.16 | 9 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $225.87 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $218.28 | 15 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $218.19 | 10 | $0 (2024) |
| Esperion Therapeutics, Inc. | $175.01 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,573 | 83 | Novartis Pharmaceuticals Corporation ($188.10) |
| 2023 | $1,337 | 67 | Merck Sharp & Dohme LLC ($185.05) |
| 2022 | $409.54 | 26 | Merck Sharp & Dohme LLC ($98.26) |
| 2021 | $291.04 | 20 | Janssen Pharmaceuticals, Inc ($68.40) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Not Applicable | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: Cardiovascular Device | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.69 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Chiesi USA, Inc. | JUXTAPID (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: WATCHMAN_IC | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Not Applicable | ||||||
| 09/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 441 | 642 | $90,033 | $33,381 |
| 2022 | 3 | 433 | 656 | $97,046 | $36,671 |
| 2021 | 2 | 141 | 188 | $27,329 | $10,764 |
| 2020 | 1 | 71 | 171 | $24,966 | $8,430 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 314 | 474 | $68,730 | $25,946 | 37.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 65 | $9,490 | $3,453 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 42 | $8,946 | $3,411 | 38.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 53 | 61 | $2,867 | $569.94 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 368 | 539 | $78,155 | $30,480 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 90 | $13,140 | $4,237 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $5,751 | $1,954 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 119 | $17,255 | $7,375 | 42.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 69 | $10,074 | $3,389 | 33.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 171 | $24,966 | $8,430 | 33.8% |
About Hannah Powers
Hannah Powers is a Family healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1932585668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hannah Powers has received a total of $3,610 in payments from pharmaceutical and medical device companies, with $1,573 received in 2024. These payments were reported across 196 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,610).
As a Medicare-enrolled provider, Powers has provided services to 1,086 Medicare beneficiaries, totaling 1,657 services with total Medicare billing of $89,246. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Chesterfield, MO
- Active Since 08/04/2015
- Last Updated 08/04/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932585668
Products in Payments
- VERQUVO (Drug) $398.23
- Repatha (Biological) $229.58
- XARELTO (Drug) $226.60
- LifeVest (Device) $218.28
- Arcalyst (Drug) $218.19
- ELIQUIS (Drug) $214.06
- LEQVIO (Drug) $175.74
- NEXLETOL (Drug) $175.01
- ENTRESTO (Drug) $173.86
- WATCHMAN Access System (Device) $162.18
- Barostim Neo System (Device) $159.57
- OPTIMIZER (Device) $140.98
- VYNDAQEL (Drug) $113.03
- CAMZYOS (Drug) $91.17
- BRILINTA (Drug) $88.23
- Optimizer (Device) $84.89
- Kerendia (Drug) $74.41
- WATCHMAN FLX (Device) $63.98
- Livalo (Drug) $62.46
- Adempas (Drug) $50.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Chesterfield
Jared Hu, Fnp-Bc, FNP-BC
Family — Payments: $20,726
Whitney Feichtner, Fnp, FNP
Family — Payments: $15,487
Jessica Kemp
Family — Payments: $10,518
Christine Mathews, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $7,177
Scott Thouvenot
Family — Payments: $6,024
Brandy Binger, Fnp-Bc, FNP-BC
Family — Payments: $3,035